Magnetic resonance arthrography is used to optimally image the detailed intraarticular anatomy of the joint space. A common iatrogenic complication of arthrography is the extra-articular injection of the gadolinium solution in the periarticular tissues; however, a less common complication involves the abnormal concentration of gadolinium within the prepared injectate. The following describes the inadvertent injection of a hyper-concentrated intraarticular solution of gadolinium and the subsequent appearance that resulted in the post-procedure magnetic resonance imaging examination. In addition, an in-vitro experiment was performed to determine the exact etiology of the abnormal magnetic resonance imaging findings that resulted in this case. The subsequent discussion revisits the signal intensity of gadolinium at extreme concentration ranges and proposes modifications of procedure protocol to mitigate the chance of a repeat event.
Magnetic resonance (MR) arthrography is the modality of choice to investigate the internal derangement of joint spaces. The study includes a preliminary procedural phase that involves the injection of the diluted gadolinium contrast solution into a joint space and a diagnostic phase that involves magnetic resonance imaging (MRI). Given that MR arthrography is a multistep process that involves at least two imaging modalities to successfully deliver the intraarticular contrast and image the patient, there are multiple opportunities for procedural errors to occur. While dilutional errors, in particular, are uncommon, these errors may occur unbeknownst to the physician or technologist until the completion of the MRI stage of the exam .
The appearance of abnormally high concentration of intraarticular gadolinium can be mistaken for pathology, resulting in diagnostic errors. Once the error is recognized, reimaging the patient involves rescheduling for a repeat injection, usually several days to weeks later to ensure that all of the contrast has been reabsorbed, returning the joint to its baseline appearance. Given the potential for the patient inconvenience, confusion with billing processes, and most importantly, the uncertain chondrotoxicity of this event, it is important that radiologists familiarize themselves with this type of error and the potential ramifications.
Previous cases of hyper-concentrated gadolinium arthrography have been documented. One such case demonstrated that there was no harm done to a patient who was injected with an aberrant concentration of gadolinium. The resultant MR images of these cases, though, found that the intraarticular space was distorted by profoundly low signal . Another report expressed how the “black” contrast effect of inadvertent administration of excessive gadolinium misrepresents any pre-existing joint pathology and must be followed up with a repeat MR arthrogram after a minimum of five hours . Though most radiologists are aware of the rare possibility for accidental gadolinium overexposure in patients receiving arthrograms, there are limited studies in the literature of the in vivo assessment of MR signal intensity with varying gadolinium concentrations .
In 2008, Bleicher and Kanal described the MRI relative signal intensity of two Federal Drug Administration approved gadolinium compounds using serial dilution. For both agents, T1 weighted signal intensities increased, peaked, and subsequently diminished as dilution factors increased and decreased, resembling a bell-shaped pattern. The hypointense or dark signal was seen in the highest and lowest concentrations of the documented serial dilutions, with a subjective optimum signal falling between the two extremes. The report concluded that two commonly used gadolinium contrast agents administered in MR imaging studies have the brightest T1 signal intensities when the serial dilutions are neither too high nor too low in concentration .
Though not readily documented, certain in-vivo reports have applied Bleicher and Kanal’s bell-shaped gadolinium curve to analyze optimal enhancement, mainly in the central nervous system [5-8]. Application of the Bleicher and Kanal bell-shaped gadolinium curve has not been applied to MR arthrography, until now. The following case describes a patient that received an inadvertent excess dose of gadolinium during an arthrogram, and the methods used to investigate the etiology of the resulting abnormal imaging findings.
Materials & Methods
A 33-year-old female presented to her orthopedist with chronic left hip pain. A left hip MR arthrogram was ordered for the diagnosis of a suspected labral tear. The patient had no relevant past medical history, and a recent pelvic radiograph performed 29 days prior to the MRI demonstrated no osseous, joint space, or soft tissue abnormalities. Following standard informed consent, history, and physical examination, an MR arthrogram was scheduled.
As per departmental protocol, a technologist prepared and labeled a diluted gadolinium contrast solution using the sterile technique, ultimately combining the components in a 20 ml syringe, which included: 10 ml of Omnipaque™ 240, 10 ml of sterile saline, 0.2 ml of gadolinium, and 0.2 ml of 1/1000 diluted epinephrine.
A fluoroscopically guided arthrogram was performed by an interventional radiologist using 1% lidocaine for local anesthesia, a 22 gauge spinal needle for intraarticular access, and the aforementioned combination of diluted gadolinium solution. Fluoroscopic images revealed contrast distention of the hip joint, confirming a successful intraarticular injection. The patient tolerated the procedure well without any immediate complications. After the contrast solution was injected, the patient obtained an MRI on a 1.2 Tesla open bore magnet (OASIS™, Hitachi Ltd., Tokyo, Japan), according to institutional protocol.
An experienced musculoskeletal radiologist’s interpretation of the MRI images revealed homogenously, profoundly hypointense T1 and T2 signal (signal void) abnormality conforming to the boundaries of the left hip joint capsule. No osseous erosions or other abnormalities were identified (Figures 1, 2).
Based on imaging findings and contemplation of potential differential diagnoses, an iatrogenic etiology was proposed involving the inadvertent administration of hyper-concentrated gadolinium into the joint space. After notifying the patient’s ordering physician, it was agreed that a short-term follow-up MRI should be performed to reassess the situation.
The patient returned two weeks following the original procedure and underwent a repeat MRI, this time without intraarticular contrast utilizing an abbreviated imaging protocol. The MRI revealed the complete resolution of the previously noted diffuse homogeneously low T1 signal associated with the left hip. The appearance of a normal left hip MRI on the abbreviated study ruled out the possibility of intrinsic disease and confirmed an iatrogenic etiology. Following this revelation, during the same day encounter, the patient’s left hip was reinjected with an intraarticular diluted gadolinium solution for the second time. A repeat left hip MR exam revealed a normal joint space with a homogenously bright/hyperintense T1 signal outlining the boundaries of the joint capsule. This study exhibited the normal T1 shortening behavior that is expected for correctly diluted gadolinium-enhanced arthrography (Figures 3, 4).
As an adjunct experiment and to further illustrate the bell-shaped signal intensity of diluted gadolinium as shown in the Bleicher and Kanal study, an in vitro investigation of multiple samples of serially diluted 10 ml vials of gadolinium was performed. The amount of 0.2 ml of gadolinium was used as the mean dilution, corresponding to the standard clinical dilution at the institution the experiment was performed. Using the same T1 parameters as in the clinical protocol, it was confirmed that gadolinium exhibits low signal at extremely high and low concentrations (Figure 5).
The tubes were then imaged using the T2 parameters dictated by institutional protocol. The images demonstrate extremely low signal at high gadolinium concentrations, and high signal at low concentrations (Figure 6).
A graph was generated based on the gadolinium dilution concentrations in comparison to their signal intensities measured on Picture Archiving and Communication Systems (PACS) (Figure 7). Each signal intensity measurement was obtained by drawing a 5 mm circular region of interest over the center of the imaged test tubes. The mean signal intensity was recorded based on the values generated by the PACS monitor.
The generated graph depicts curves consistent with the imaging appearance of the test tubes. There are two points at which the curves demonstrate intersecting values; the first intersecting concentration is seen at the 0.1:20 concentration, and the other at the 0.8:10 concentration. At the 0.1:20 concentration, MR arthrographic imaging findings reflect high signal contrast in the joint space on both T1 and T2 weighting. This concentration is considered diagnostic for MR arthrography. one of the industry standards for an arthrography. The second value at which the curves nearly intersect is at the 0.8:10 concentration. It is at this hyper-concentrated level that one would expect dark/signal void of the joint space on T1 and T2 weighted images, as presented in this case.
The preceding study highlights a rarely seen iatrogenic complication of MR arthrography involving the incorrect concentration of gadolinium. The ramification of this error produces altered imaging characteristics that can mislead those who are not aware of this entity. Differential diagnosis of intraarticular air, pigmented villonodular synovitis (PVNS), or hemorrhage, could all be considered if low T1 and low T2 signal material is seen in the joint space. Intraarticular air would produce characteristic "bubbles" of susceptibility artifact, a finding that was not apparent on any of the MR images obtained in this case. When considering PVNS, there is typically a low signal nodular appearance with a “blooming” susceptibility artifact associated with hemosiderin deposition. The abnormality, in this case, had a confluent, non-nodular appearance, without imaging artifacts. Similarly, diffuse hemarthrosis would yield hemosiderin deposition and possibly a hematocrit layering effect. None of these findings were evident in this case, leaving the remaining differential diagnosis of hyper-concentrated intraarticular gadolinium solution as a primary consideration. Furthermore, the normal appearance of the left hip as noted on a short term follow-up MRI strengthens the supposition of an iatrogenic error in the initial visit. It is important to mention that while hypoconcentrated gadolinium exhibits hypointense signal on T1 weighted imaging, and high signal on T2 weighted imaging, hyper-concentrated gadolinium exhibits low signal on both T1 and T2 weighted imaging. The low T2 signal intensity observed at increasing concentrations of gadolinium is the result of decreasing water in solution. Therefore by deduction, it can be concluded that the error encountered in this case was from a hyper-concentrated gadolinium solution.
While the exact cause of this error could not be elucidated in a retrospective analysis, one possible explanation is that instead of adding 10 ml of sterile saline to the solution as per the institutional protocol, 10 ml of gadolinium could have been added inadvertently. The saline and gadolinium are both supplied in 10 ml vials, which could appear similar if viewed at a glance. An alternative, less likely, the explanation could be that the concentration of gadolinium was altered during the manufacturing process.
The preceding case and error prompted a review of arthrographic procedures at the inpatient and outpatient sites of the institution where the patient received care. As a result of the findings, the institution has produced a policy that no longer permits technologists to prepare arthrographic solutions. Moreover, radiologists performing arthrographic procedures now must prepare the gadolinium solution shortly before injection. While this policy does not completely eliminate the risk of dilution errors, it does comply with United States Pharmacopeia 797 recommendation regarding non-physician compounding of pharmaceuticals . Other institutions have enlisted their pharmacies to prepare all arthrographic solutions, and subsequently, deliver the preparation to the radiology department shortly before the injection time . Using the pharmacy in this role removes all compounding responsibility from the radiology department.
While the patient in concern did not have any contemporary ill-effects, and the overall systemic dose of gadolinium was less than seen in most MR studies requiring intravenous gadolinium contrast enhancement, this case does raise the question of chondrotoxicity. Long-term effects on the cartilage of patients exposed to increased concentrations of intraarticular gadolinium have not been thoroughly studied; however, there is a threshold concentration that is known to be chondrotoxic to cartilage in vitro .
Radiologists should be aware of the bell-shaped signal intensity curve that gadolinium demonstrates on T1 imaging in order to recognize the potential complication of hyperconcentrated intraarticular gadolinium. Furthermore, even though it may be an uncommon error, radiologists should be able to recognize the differences between an inadvertent hyperconcentrated gadolinium injection and other intraarticular pathology. Finally, physicians should be mindful of the possibility of a dilutional error during the preparation of gadolinium solutions for MR arthrography.
- Newberg AH, Munn CS, Robbins AH: Complications of arthrography. Radiology. 1985, 155:605-606. 10.1148/radiology.155.3.4001360
- Genovese EA, Bertolotti E, Fugazzola C: Erroneous intra-articular injection of gadolinium solution at 0.5 mol/l concentration: a case report. Cases J. 2009, 2:e9320. 10.1186/1757-1626-2-9320
- Aydingoz U, Kerimoglu U, Canyigit M: "Black" contrast effect during magnetic resonance arthrography attributable to inadvertent administration of excessive gadolinium chelates. J Comput Assist Tomogr. 2005, 29:333-335. 10.1097/01.rct.0000163571.79381.15
- Bleicher AG, Kanal E: A serial dilution study of gadolinium-based MR imaging contrast agents. AJNR Am J Neuroradiol. 2008, 29:668-673. 10.3174/ajnr.A0905
- Essig M, Lodemann KP, Le-Huu M, Brüning R, Kirchin M, Reith W: Intraindividual comparison of gadobenate dimeglumine and gadobutrol for cerebral magnetic resonance perfusion imaging at 1.5 T. Invest Radiol. 2006, 41:256-263. 10.1097/01.rli.0000191333.19068.6b
- Essig M, Tartaro A, Tartaglione T, Pirovano G, Kirchin MA, Spinazzi A: Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators. Acad Radiol. 2006, 13:744-751. 10.1016/j.acra.2006.02.056
- Kuhn MJ, Picozzi P, Maldjian JA, et al.: Evaluation of intraaxial enhancing brain tumors on magnetic resonance imaging: intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for visualization and assessment, and implications for surgical intervention. J Neurosurg. 2007, 106:557-566. 10.3171/jns.2007.106.4.557
- Maravilla KR, Maldjian JA, Schmalfuss IM, et al.: Contrast enhancement of central nervous system lesions: multicenter intraindividual crossover comparative study of two mr contrast agents. Radiology. 2006, 240:389-400. 10.1148/radiol.2402051266
- General Chapter <797> Pharmaceutical Compounding - Sterile Preparations. (2018). Accessed: September 22, 2019: http://www.usp.org/compounding/general-chapter-797.
- Adams CC, Loewen MJ, Breckenridge IA, Besich-Carter JE, Bush LA: How we do it: shifting MR arthrogram compounding from the fluoroscopy suite to the sterile pharmacy. Skeletal Radiol. 2019, 48:445-448. 10.1007/s00256-018-2980-y
- Oznam K, Sirin DY, Yilmaz I, et al.: Lopromide- and gadopentetic acid-derived preparates used in MR arthrography may be harmful to chondrocytes. J Orthop Surg Res. 2017, 12:e98. 10.1186/s13018-017-0600-5
The Dark Side of Gadolinium: A Study of Arthrographic Contrast at Extreme Concentrations
Ethics Statement and Conflict of Interest Disclosures
Human subjects: Consent was obtained by all participants in this study. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
We would like to thank the following technologists at the University of Florida College of Medicine- Jacksonville: D’waun Murphy, Kevin Fay, Kendall O’Connor, Amber Edwards, Jack Idell, Robert Hester, Nedra Jordan, Jeanette Jackson, Marquita Davis, Barbara Fields, Marc Roberts, and Kevin Cuda.
Cite this article as:
Kurra C, Harmon T S, Taylor K, et al. (October 27, 2019) The Dark Side of Gadolinium: A Study of Arthrographic Contrast at Extreme Concentrations. Cureus 11(10): e6006. doi:10.7759/cureus.6006
Received by Cureus: September 27, 2019
Peer review began: October 16, 2019
Peer review concluded: October 23, 2019
Published: October 27, 2019
© Copyright 2019
Kurra et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 3.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.